NLRP3 and alkaline phosphatase measurement: Emerging pharmacological evidence has demonstrated that TCM prescription, extract, and active ingredient mitigated AP progression by suppressing NLRP3 inflammasome activation and downstream pyroptosis pathways (Jiang et al., 2021; Zeng et al., 2024; An et al., 2025).